Theranos Founder & CEO Elizabeth Holmes in Conversation with KQED's Michael Krasny

Elizabeth Holmes believed from an early age that starting her own company would afford her the greatest opportunity to make change in the world. She left Stanford at 19 to found Theranos – an amalgam of the words "therapy" and "diagnosis" in 2003. It's now worth more than $9 billion, with 500 employees, headquartered in Palo Alto. In addition to being its founder & CEO, she is a co-inventor on 82 U.S. and 189 foreign patent applications, of which 18 in the U.S. and 66 abroad have been granted.

Holmes is using her background in engineering and technology to disrupt the diagnostic laboratory industry. Theranos' mission is to make actionable health information accessible to people everywhere in the world at the time it matters, enabling early detection and intervention of disease, and empowering individuals with information to live the lives they want to live. Because she believes access to real-time, affordable diagnostic information is a human right, Holmes has created blood tests which require just a few drops of blood to perform up to 70 tests. By optimizing the chemistry used and leveraging software, Theranos' labs can perform these tests faster, cheaper and with much less discomfort.

We're very pleased to welcome KQED's Michael Krasny back to our stage to moderate an in-depth conversation with a woman who wants nothing less than to revolutionize the health care system using technology, creativity and innovation.